Paydirt
VP
Insider

Venrock Healthcare Capital Partners EG, L.P.

10% owner

Venrock Healthcare Capital Partners EG, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in KALV. The largest single filing was $3.6M of KALV (211,288 sh across 3 lots, as filed), executed Mar 25.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.6M
shares × price, as filed
Last traded
Mar 26
Filed Mar 27
Open performance→
Volume by month
$3.6M$1.8M$0Oct 2024Apr 2025Oct 2025Apr 2026Apr 2025 · buys $236KMar 2026 · sells $3.6M
Buys $236K Sells $3.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names
KALV KALV KALV · 1 buy · 1 sell 2 filings
Recent filings
KALVSALE KalVista Pharmaceuticals, Inc. View filing → $3.6M
211,288 sh across 3 lots
Exec Mar 25
Filed Mar 27 · 5:30 PM ET KALVPURCHASE KalVista Pharmaceuticals, Inc. View filing → $236K
25,000 sh × $9.42
Exec Apr 9 2025
Filed Apr 11 2025 · 5:30 PM ET